Abbott Laboratories (NYSE:ABT) is one of Goldman Sachs top healthcare stocks. On March 10, Abbott Laboratories (NYSE:ABT) ...

Abbott, the global healthcare company, today announced the launch of XIENCE Skypoint in India. This is Abbott’s most advanced ...

GHAZIABAD, India, Jan 23 (Reuters) - Indian drugmaker Abbott Healthcare's supply chain is being scrutinised as part of a wider investigation into the alleged misuse of its codeine-based cough syrup ...

Abbott launches ICRAS Tool to enable early identification of diabetes related heart and kidney risks: Our Bureau, Bengaluru Thursday, March 12, 2026, 17:15 Hrs [IST] Abbott has an ...

Abbott launches XIENCE Skypoint drug-eluting stent in India, designed to treat complex heart artery blockages and support doctors in advanced cardiovascular care.

BENGALURU, Aug 9 (Reuters) - Abbott India (ABOT.NS), opens new tab, the Indian arm of U.S. healthcare firm Abbott Laboratories (ABT.N), opens new tab, reported a 41% rise in its first-quarter profit ...

The new device, XIENCE Skypoint, is designed to be more flexible, easier to guide through the heart's arteries, including large vessels, and better suited for treating complex heart blockages ...

Abbott has teamed up with Novo Nordisk India to launch Extensior, a second brand of the diabetes drug semaglutide, aiming to expand access to GLP-1 therapy in India.